Novartis Kymriah® showed strong response to high-risk patients with relapsed or refractory follicular lymphoma during long-term study follow-up – QNT Press Release5 years ago
AlloVir announced the positive preliminary data of Phase 2 of the ongoing Posoleucel polyvirus prevention study at the 63rd Annual Meeting of the American Society of Hematology – QNT Press Release5 years ago